Full text
| |
| Author(s): |
Juliana Moreira
Total Authors: 1
|
| Document type: | Doctoral Thesis |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI) |
| Defense date: | 2009-04-23 |
| Examining board members: |
Antonio Condino Neto;
Edson Antunes;
Maria Heloisa Souza Lima Blotta;
Luciana Cezar de Cerqueira Leite;
Sonia Jancar Negro
|
| Advisor: | Antonio Condino Neto |
| Abstract | |
Epidemiological studies have indicated that the BCG vaccination may induce a protective immune response that can go beyond what is obtained against tuberculosis. This vaccine is associated to the induction of Th1 immune response, increase antibodies response to unrelated antigen, less atopy, less anergy and a reduction in childhood mortality. Nevertheless, the mechanisms that sustain these non-specific effects remain unclear. We investigated the effects of different BCG preparations (viable BCG and two inactivated BCG EFD BCG and HK BCG) over the NADPH oxidase, the TLR-2 gene expression and over the modulation of the cytokine production (IL-12p40, TNF-a, IFN-g and IL-10) by human leukocytes in vitro. The results demonstrated that different BCG preparations induce different responses, as in respect to the activity of the NADPH oxidase system as in relation to the modulation of cytokine production by human leukocytes in vitro. Beyond this we demonstrated that in inflammatory conditions as asthma, the modulation of cytokine production by the BCG is different of that observed in healthy individuals. (AU) | |